Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Zevra Therapeutics (ZVRA) over the last 4 years, with Q3 2025 value amounting to $64000.0.

  • Zevra Therapeutics' Exchange Rate Effect rose 11303.46% to $64000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 67348.48%. This contributed to the annual value of $454000.0 for FY2024, which is 93181.82% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Exchange Rate Effect of $64000.0 as of Q3 2025, which was up 11303.46% from $658000.0 recorded in Q2 2025.
  • Zevra Therapeutics' Exchange Rate Effect's 5-year high stood at $671000.0 during Q4 2024, with a 5-year trough of -$491000.0 in Q3 2024.
  • Over the past 4 years, Zevra Therapeutics' median Exchange Rate Effect value was $64000.0 (recorded in 2025), while the average stood at $80923.1.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 78000.0% in 2023, then surged by 21902.99% in 2024.
  • Zevra Therapeutics' Exchange Rate Effect (Quarter) stood at $189000.0 in 2022, then skyrocketed by 84.66% to $349000.0 in 2023, then surged by 92.26% to $671000.0 in 2024, then crashed by 90.46% to $64000.0 in 2025.
  • Its Exchange Rate Effect stands at $64000.0 for Q3 2025, versus $658000.0 for Q2 2025 and -$372000.0 for Q1 2025.